Who We Fund
Since 1949, LLS has provided more than $1.8 billion to the best and the brightest blood cancer researchers and biotech companies to support their groundbreaking research. Meet grantees and the companies who’ve joined our fight to find cures and help blood cancer patients everywhere.
Sisi Chen
leukemia
Rizwan Romee
Immunotherapy
Todd Fehniger
NK/CART cell therapy for lymphomas and pediatric AML
Neha Mehta-Shah
T-cell lymphoma
Sheng Li
Aging and AML
Jonathan Licht
DNA biology, myeloma
Grzegorz Nowakowski
Clinical trial access
Simona Colla
Myeloma biology
Inhye Ahn
CLL
Dan Landau
cancer evolution biology
Alison Moskowitz
lymphoma therapeutics
Robert Soiffer
transplantation
Rajni Kumari
AML
Lev Kats
myeloma and epigenetics
Armin Rashidi
gut bacteria and transplant success
Philippe Armand
follicular lymphoma
Cailin Collins
Leukemia and pre-leukemia
Jianhua Yu
myeloma immunotherapy
Hong Wen
AML
Paul Beavis
immunotherapy in myeloma
Piers Patten
COVID-19
Tomasz Skorski
myeloproliferative neoplasms, AML
Christian Marinaccio
MLL leukemias
Trent Hall
MDS
Andrew Lane
BPDCN
Kirk Schultz
pediatric transplantation
Riccardo Dalla-Favera
lymphoma (DLBCL)
Wendy Stock
T-cell ALL
Gianpietro Dotti
CAR T and AML
Caroline Arber
myeloma CAR-T
James Rubenstein
Lymphoma of the Central Nervous System
Amin Sobh
Myeloma biology
Ramon Massoni-Badosa
CLL and Richter's Syndrome
Jaehyuk Choi
T-cell lymphoma
Reina Takeda
AML
Ravi Bhatia
transplantation
Nataly Cruz-Rodriguez
T-ALL and metabolism
Daniel Starczynowski
MDS and AML
Faron Pharmaceuticals
immunotherapy, MDS
Gaurav Goyal
Erdheim-Chester Disease
Suzanne Lentzsch
Myeloma
Julia Paczkowska
immunobiology of Hodgkin's disease
Eirini Papapetrou
blood cancer stem cells
Justine Kahn
pediatric leukemia and lymphoma
Jennifer Lewis
URM Student
Courtney DiNardo
clinical trials, AML
Mendel Goldfinger
MDS/AML trials for the elderly
Bingyi Chen
AML immunotherapy
Catriona Jamieson
cancer stem cell biology
Kerry Rogers
CLL
Takeshi Sugio
T-cell lymphoma
Marco Ruella
Immunotherapy for T-cell lymphoma
Peter Croucher
Multiple Myeloma
Yiman Liu
Epigenetics and leukemia
Daisuke Nakada
preleukemia, leukemia
Nicolas Nassar
pediatric leukemia
Lei Ding
myeloproliferative neoplasms, myelofibrosis
Shazia Nakhoda
Equity in Access
Huda Salman
CMML
Frederick Locke
lymphoma and immunotherapy
Alieen Rowan
Adult T cell leukemia/lymphoma
Ronald Levy
immunotherapies, COVID-19
Sriram Sundaravel
AML stem cells
Marc Seifert
Hairy cell leukemia
Marina Konopleva
MDS/AML metabolism
Kimberly Stegmaier
childhood blood cancers
Anthony Letai
improving CAR-T
Richard Lock
T-ALL
Alex Kentsis
pediatric leukemias
Thomas LeBlanc
palliative care
Peter Klein
MDS
Stephen Gottschalk
pediatric leukemia and CAR-T
Suman Paul
T cell cancers and immunotherapy
Kura Oncology
MLL leukemia, AML
Jalpa Doshi
Equity in Access
Koichi Takahashi
AML/MDS
Siddhartha Jaiswal
preleukemia
Anushree Vichare
Equity in Access
Jianguo Tao
Mantle Cell Lymphoma
Xu Ji
Equity in Access
Matthew Frank
Lymphoma CART therapy
Areej El-Jawahri
transplant survivorship
Ravindra Majeti
preleukemia, AML
Patrizia Mondello
IgM MGUS & Waldenstrom Macroglobulinemia
Eugenio Morelli
Myeloma
Michael Savona
MDS and leukemia
Mala Shanmugam
myeloma
Jenny Wang
AML
Caribou Biosciences
immunotherapy, allo-CAR, NHL, MM, AML
Jessica Stewart
Epstein-barr virus and lymphomas
Alexey Danilov
lymphoma
Yan Liu
MDS
Megan McNerney
AML/MDS
Michael Keller
COVID-19, immunotherapy
Rong Lu
preleukemia, leukemia
Jean Koff
Disparities in DLBCL
Jake Shortt
precision therapy for aggressive lymphomas
Alec Zhang
myeloma, immunotherapy
Luca Busino
DLBCL
Raymond Mailhot
Equity in Access
Michaela Reagan
Multiple Myeloma
Abintus Bio
immunotherapy, in vivo CAR
Tanya Siddiqi
clinical trial access
Sham Mailankody
Myeloma immunotherapy clinical trials
Bruno Paiva
smoldering myeloma
Liran Shlush
pre-leukemia
Qing Yi
Novel CAR-T
Alfred Garfall
myeloma immunotherapy
Stephen Nimer
myeloid cancer biology
Soheil Meshinchi
pediatric AML
Markus Muschen
leukemia and lymphoma biology
Nirav Shah
CAR-T for lymphoma
Mark Dawson
B-ALL and CAR-T resistance
Dimericon Therapeutics
dimericons, blood cancer
Logan Spector
childhood leukemia epidimiology
Keisuke Ito
blood cancer stem cells and MDS metabolism
Rgenta Therapeutics
RNA-targeting, blood cancer
Anita Kumar
Mantle Cell Lymphoma immunotherapy
Leandro Cerchietti
DLBCL
Srividya Swaminathan
pediatric, immunotherapy
Elliot Stieglitz
CMML
Immunitas Therapeutics
immunotherapy, DLBCL, Hodgkin's
Sigurður Kristinsson
Smoldering myeloma
Roberta Zappasodi
lymphoma, immunotherapy
Tycel Phillips
Mantle Cell Lymphoma
Wendy Béguelin
follicular lymphoma
Pietro Genovese
transplant and AML
Thomas Kipps
Hairy Cell Leukemia
Pooja Khandelwal
bone marrow transplantation
Bing Carter
p53 mutant AML
Lakshmi Nayak
brain tumors in lymphoma
F. Lennie Wong
Equity in Access
Taishi Yonezawa
AML
Brian Dalton
DNA mutations and myeloid cancers
Maximilian Stahl
AML immunotherapy
Jennifer Woyach
CLL trials
Lori Muffly
Equity in Access
Qingyu Luo
BPDCN
Yubin Zhou
peripheral T cell lymphoma
Rayne Rouce
Immunotherapy for pediatric, adolescent & young adult patients
Michael Green
lymphoma biology
Ruben Carrasco
Myeloma
Stacie Dusetzina
Equity in Access
Carl Allen
pediatric blood cancers
Ryan Wilcox
T-cell lymphoma
Jeremy Baeten
AML
Affimed
immunotherapy, HL, PTCL
Shannon Maude
Immunotherapy for ALL
Tak Mak
Immunotherapy
Ann-Kathrin Eisfeld
Racial diversity in AML
Lindsey Montefiori
pediatric leukemia
Steven Treon
Lymphomas and Waldenstrom's
Teresa Palomero
Peripheral T-cell Lymphoma
Ari Melnick
epigenetics and lymphoma
Paolo Caimi
CAR-T clinical trial for CLL
Julia Maxson
AML
Bailee Kain
AML and African ancestry
Jayna Mistry
aging and leukemias
Sahand Hormoz
MPN
Christian Steidl
B-cell lymphomas
Fenghuang Zhan
Myeloma and bone disease
Thorsten Zenz
Hairy cell leukemia
Adam Olszewski
Follicular and marginal zone lymphoma
Stephen Oh
myeloproliferative neoplasms
Jing Yang
Myeloma
Daniel Herranz
T-ALL
Timothy Graubert
AML and MDS biology
Eric Padron
CMML
Meng Li
Equity in Access
Caner Saygin
T-ALL
Eric Pietras
AML
Dane Vassiliadis
blood cancer biology
Venkata Lokesh Battula
immunotherapy and AML
Constantine Mitsiades
CAR-T and CAR-NK immunotherapies
Michael Wang
Mantle Cell Lymphoma
Roland Walter
Antibody-based AML therapies
Paolo Strati
Non-Hodgkin Lymphoma
Mark Murakami
follicular lymphoma
John Crispino
MPNs, myelofibrosis
Grant Challen
preleukemia, leukemia
John Leonard
lymphoma research
Zachary Epstein-Peterson
Peripheral T-cell lymphoma trial
Ivan Odak
Non-Hodgkin's Lymphoma immunotherapy
Christopher Booth
BPDCN
Carma Bylund
Equity in Access
Britta Will
Leukemia and pre-leukemia
Carl June
CAR T immunotherapy
Nicola Vannini
Aging and CAR-T success
Kymera Therapeutics
protein degraders, TCL, LGLL, AML
Madhav Dhodapkar
multiple myeloma immunotherapy
Ricky Johnstone
lymphoma and myeloma
Mark Hamilton
DLBCL and CAR-T
Daniel Thomas
Myelofibrosis
Sergei Doulatov
Leukemias
Omar Abdel-Wahab
Hairy cell leukemia
Jolanta Grembecka
leukemia therapeutics
Anouchka Laurent
T-cell lymphoma
Jonathon Cohen
lymphoma clinical trial access in Georgia
Nicoletta Cieri
AML and transplantation
Saar Gill
AML immunotherapy
Michael Kharas
leukemia
Thomas Koehnke
leukemia
H. Irene Su
Equity in Access
Sam Butterworth
CMML
Oreofe Odejide
Equity in Access
Kathleen Sakamoto
pediatric AML
Fahmin Basher
transplant and GvHD
Jonas Jutzi
myeloproliferative neoplasms
William Matsui
Myeloma
Gareth Morgan
smoldering myeloma, MGUS
Brian Walker
smoldering myeloma, MGUS
Susan Schwab
cancer immunology
Jun Qi
Myeloma
Randall Davis
CLL
Enrico Tiacci
Hairy cell leukemia
Hao Jiang
DNA biology and leukemia
Noemí Puig Morón
Myeloma
Yibin Yang
Lymphoma
Christopher Flowers
clinical trial access
Sarah Tasian
pediatric leukemias
Kasey Leger
pediatric blood cancers
George Daley
"off-the-shelf" CAR-T and CAR-NK
Jennifer Trowbridge
aging and leukemia
Catherine Smith
leukemia
Jing Fu
myeloma
Margaret Shipp
lymphoma biology
Steven Horwitz
T-cell lymphomas
Jeetayu Biswas
splicing in myeloid diseases
Manyi Wei
acute megakaryoblastic leukemia
Jaroslaw Maciejewski
bone marrow failure
Catherine Bollard
pediatric blood cancers and immunotherapy
Ana Vujovic
AML
Jane Oliaro
Myeloma & Lymphoma Immunotherapy
Constellation Pharmaceuticals
myeloproliferative neoplasms
Arash Alizadeh
blood cancer biology and diagnosis
Lawrence Boise
CART and myeloma
Jeffrey Magee
pediatric AML
Nizar Bahlis
Myeloma immunotherapy
Joachim Yahalom
Lymphoma
Frederike Kramer
MPNs
Adam de Smith
pediatric ALL and Down Syndrome
Adi Nagler
Bronchiolitis obliterans after transplant
Dren Bio
immunotherapy, cytotoxic lymphomas, LGLL
Amit Verma
AML/MDS
Liling Wan
AML
Immune-Onc Therapeutics
immunotherapy, AML, CMML
Daniel Pollyea
AML
Tyler Parsons
MPN and AML
Caron Jacobson
lymphoma and immunotherapy
Enterome
vaccine, FL, MZL
Christopher Porter
Leukemia, lymphoma
Christine Zhang
AML
ImCheck Therapeutics
immunotherapy, AML
Nitin Jain
CLL
Vittoria Biotherapeutics
immunotherapy, CAR-T, TCL
Siegfried Janz
Myeloma immunotherapy
John DiPersio
trispecific antibody for AML and MDS
Helen Parsons
Equity in Access
Craig Jordan
AML
Steven Park
follicular lymphoma
Ryvu Therapeutics
AML, MDS, Myelofibrosis
Courtney Jones
AML metabolism
Daniel Lucas
bone marrow and leukemia biology
Martin Dreyling
Mantle Cell Lymphoma
Coleman Lindsley
AML/MDS
Robert Orlowski
(Smoldering) Multiple Myeloma
Lucy Godley
preleukemia
Matteo Bellone
Smoldering multiple myeloma
BioInvent International
immunotherapy, indolent NHL, CTCL
George Vassiliou
Leukemia Prevention
Catherine Diefenbach
DLBCL immunology
Yoke Seng Lee
AML